Valeant Cuts Deal With Walgreen To Distribute Products

0
Valeant Cuts Deal With Walgreen To Distribute Products

Valeant Pharmaceuticals has made a deal with Walgreens Boots Alliance to distribute a number of its medicines at a discount through Walgreens pharmacies. The news of the new distribution agreement comes just a month and a half after ending a distribution contract with a specialty pharmacy accused of unethical business practices.

Valeant, which has recently been under fire for the high prices of many of its drugs, will reduce prices by 10% for its branded dermatology and ophthalmology products distributed by Walgreens retail pharmacies, and will be extending the model to other independent retail pharmacies in the future, according to the statement released Monday. The long-term deal includes over 8,000 U.S. Walgreens pharmacies, and begins in the first quarter of next year. The contract covers medicines including the toenail fungus drug Jublia, acne products Solodyn and Retin-A Micro and eye drop Alrex. Valeant’s over-the-counter healthcare products will now also be available at Walgreens.

Massif Capital’s Top Short Bets In The Real Asset Space [Exclisuve]